MicroRNAs as Biomarkers and Therapeutic Targets in Doxorubicin-Induced Cardiomyopathy: A Review

Overview of attention for article published in Frontiers in Cardiovascular Medicine, November 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,357 followers.

We've detected a paper from Frontiers in Cardiovascular Medicine that cites a retracted paper post-retraction. Citing paper: https://t.co/Bzs0JWnjOq Retracted paper: https://t.co/gOl2JXNwnP

25 Dec 2021

Reply Repost Favourite

New Research: MicroRNAs as Biomarkers and Therapeutic Targets in Doxorubicin-Induced Cardiomyopathy: A Review: Doxorubicin is a broad-spectrum chemotherapy drug applied in antitumor therapy. However, its clinical utility is limited by its… https://t.co/Dj8

25 Nov 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.